CryoLife (United States)
Artivion, Inc. is a distributor of cryogenically preserved human tissues for cardiac and vascular transplant applications and develops medical devices. Among its products are human heart valves, which are treated to remove excess cellular material and antigens, and BioGlue surgical adhesive. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for CryoLife (United States), United States, covering academic research published from 2000 to 2024. Read More.
Open Access Percentage
49%
Total
Publications
148
Total Open
Publications
72
Total
Citations
3.3K
Open Access
Percentage
49%
Total
Publications
148
Total Open
Publications
72
Total
Citations
3.3K
Breakdown
Publisher Open
37%
Both
9%
Other Platform Open
3%
Closed
51%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 19%
13
Hybrid 68%
46
No Guarantees 13%
9
Other Platform Open
Domain 68%
13
Institution 21%
4
Other Internet 21%
4
Preprint 11%
2
Public 0%
0
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 13 |
DOI | Other Internet | 3 |
DANS - Data Archiving and Networked Services | Institution | 2 |
Unknown Repository | Other Internet | 1 |
University of Milano-Bicocca - BOA | Institution | 1 |
U.S. Department of Energy Office of Scientific and Technical Information - OSTI OAI | Institution | 1 |
OSF Preprints - Arabixiv | Preprint | 1 |
Imperial College London - Spiral | Institution | 1 |
DASH - Digital Access to Scholarship at Harvard | Institution | 1 |
arXiv | Preprint | 1 |